Beta Glucan 500 and Biological Age and Immune Age

OvationLab60 enrolled

Overview

The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Beta Glucan 500 on a variety of validated markers of biological and immune age on the comprehensive TruAge panel (TruDiagnostics, Lexington, KY).

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Aging

Interventions

Beta GlucanDIETARY_SUPPLEMENT

12 weeks of supplementation with two capsules daily of BWH Labs Beta Glucan 500

Eligibility

Sex: ALLMin age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Adult females or males age ≥ 40 years 2. Ability to read and speak English 3. Previous completion of a TruDiagnostic TruAge test within the past three months to enable comparison of previous biomarkers to the same biomarkers after intervention 4. DunedinPACE estimate of aging \>0.9 Exclusion Criteria: 1. Current diagnosis and treatment for an autoimmune condition 2. Current use of beta-glucan or mushroom dietary supplement 3. Known allergies to beta glucan, yeast, or mushrooms 4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks 5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol 6. Participants unable to provide consent

Locations (1)

OvationLab

Richmond, Virginia, United States

Outcomes

Primary Outcomes

Epigenetic Testing

Time frame: Change from baseline to 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.